Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction

Author:

Enoki Yuki1,Watanabe Hiroshi12,Arake Riho1,Fujimura Rui1,Ishiodori Kana1,Imafuku Tadashi1,Nishida Kento1,Sugimoto Ryusei1,Nagao Saori1,Miyamura Shigeyuki1,Ishima Yu3,Tanaka Motoko4,Matsushita Kazutaka4,Komaba Hirotaka5,Fukagawa Masafumi5,Otagiri Masaki67,Maruyama Toru12

Affiliation:

1. Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences; Kumamoto University; Kumamoto Japan

2. Center for Clinical Pharmaceutical Sciences, School of Pharmacy; Kumamoto University; Kumamoto Japan

3. Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences; Tokushima University; Tokushima Japan

4. Department of Nephrology; Akebono Clinic; Kumamoto Japan

5. Division of Nephrology, Endocrinology, and Metabolism; Tokai University School of Medicine; Kanagawa Japan

6. Faculty of Pharmaceutical Sciences, Sojo University; Kumamoto Japan

7. DDS Research Institute, Sojo University; Kumamoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3